Asensus Surgical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
28 Février 2024 - 12:55PM
Asensus Surgical, Inc. (NYSE American: ASXC) announced today that
Shameze Rampertab, Executive Vice President and Chief Financial
Officer, will participate in the Oppenheimer 34th Annual Healthcare
MedTech & Services Conference. The Company’s virtual
presentation will take place on Tuesday, March 12, 2024 at 4:40 pm
Eastern Time.
The conference webcast will be available online on the investor
relations page of the Company’s website at
https://ir.asensus.com/events-and-presentations. Replays of the
webcasts will be archived on the website for approximately 90
days.
About Asensus Surgical, Inc.
Asensus Surgical is revolutionizing surgery with the first
intra-operative Augmented Intelligence technology approved for use
in operating rooms around the world. Recognized as an award-winning
leader in digital technology, Asensus is committed to making
surgery more accessible and predictable while delivering
consistently superior outcomes. The Company’s novel approach to
digitizing laparoscopy has led to system placements globally. Led
by engineers, medical professionals, and industry luminaries,
Asensus is powered by human ingenuity and driven by collaboration.
To learn more about the Senhance® Surgical System and the new LUNA™
System, visit www.asensus.com.
Follow Asensus
Email Alerts: https://ir.asensus.com/email-alerts
LinkedIn:
https://www.linkedin.com/company/asensus-surgical-inc/
Twitter: https://twitter.com/AsensusSurgical
YouTube: https://www.youtube.com/@AsensusSurgical
TikTok: https://www.tiktok.com/@asensus_surgical
INVESTOR CONTACT:
Mark Klausner or Mike Vallie, 443-213-0499
invest@asensus.com
MEDIA CONTACT:
Dan Ventresca
Matter Communications
AsensusPR@matternow.com
617-874-5488
Asensus Surgical (AMEX:ASXC)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Asensus Surgical (AMEX:ASXC)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024